The current, fragmented set of primary health services with their emphasis on managing ill health rather than promoting health and wellbeing are not meeting the needs of people with chronic conditions. We need to start putting the services together so they actually form a system that has at its heart the consumer.
CHF's Submission to the Primary Health Care Advisory Group Survey on the Discussion Paper: Better Outcomes for People with Chronic and Complex Conditions through Primary Health Care.
CHF supports the effective, safe and successful entry of biosimilars into the Australian market. This is in the interest of consumers as they will have access to a wider group of therapeutic options. In line with the National Medicines Policy safe and effective medicines should be available to consumers at the lowest possible cost. Patients should not have to pay more for a biosimilar than a reference brand.
Leanne Wells, Chief Executive Officer, Consumers Health Forum of Australia, gave the Ian Webster Health for All Oration to the annual forum of the Centre for Primary Health Care and Equity on 13 August 2015.
The Working Together Guide provides guidance and examples for building collaborative relationships between individuals, health consumer organisations and research-based pharmaceutical companies.
The Working Together Guide was developed by the Consumers Health Forum of Australia and Medicines Australia in 2005 and was first updated in 2008.
CHF's comments on the Review of the implementation of the national reform agenda on organ and tissue donation and transplantation.
On 30 June 2015 CHF CEO Leanne Wells spoke to the Melbourne Institute Public Economic 'Towards a Stronger Medicare' Forum at the National Press Club.
CHF has been engaged with the development of an electronic health record and system since its inception, and our submission is drawn from submissions into previous inquiries into the Personally Controlled Electronic Health Record (PCEHR) and similar issues, as well as the experiences of our consumer representatives on key committees.
So far in 2015, on behalf of members, CHF has...
The major implication of these results for health policymakers is that defenders of traditional “silos” of medicine need to rethink what ought to be considered traditional roles for GPs and pharmacists. Moreover, if pharmacists are going to assume a greater role in the provision of primary care services, then the industry is going to have to think through what training and accommodation will be necessary to give consumers the confidence that these services do not compromise the quality they have come to expect from GPs.